MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 1 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,074 | +111.0% | 46,722 | +484.4% | 0.00% | – |
| Q2 2023 | $2,878 | +28680.0% | 7,995 | -62.4% | 0.00% | – |
| Q1 2023 | $10 | +25.0% | 21,255 | +31.0% | 0.00% | – |
| Q4 2022 | $8 | -99.9% | 16,231 | -16.1% | 0.00% | – |
| Q3 2022 | $12,000 | +140.0% | 19,349 | +245.1% | 0.00% | – |
| Q1 2022 | $5,000 | -91.7% | 5,607 | -87.8% | 0.00% | -100.0% |
| Q3 2021 | $60,000 | -27.7% | 45,936 | -41.9% | 0.00% | +100.0% |
| Q1 2021 | $83,000 | +730.0% | 79,023 | +965.9% | 0.00% | – |
| Q4 2020 | $10,000 | – | 7,414 | +7314.0% | 0.00% | – |
| Q3 2020 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q2 2020 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 100 | -98.2% | 0.00% | – |
| Q2 2018 | $2,000 | -92.0% | 5,529 | -73.9% | 0.00% | -100.0% |
| Q4 2017 | $25,000 | – | 21,181 | +264662.5% | 0.00% | – |
| Q3 2017 | $0 | -100.0% | 8 | -99.9% | 0.00% | -100.0% |
| Q2 2017 | $22,000 | – | 13,260 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 10,188,312 | $11,105,000 | 1.28% |
| Stonepine Capital Management, LLC | 2,008,006 | $2,189,000 | 1.26% |
| CVI Holdings, LLC | 909,625 | $991,000 | 0.94% |
| Vivo Capital, LLC | 6,818,181 | $7,432,000 | 0.74% |
| Broadfin Capital, LLC | 2,727,272 | $2,973,000 | 0.61% |
| Telemetry Investments, L.L.C. | 650,000 | $708,000 | 0.36% |
| Granite Point Capital Management, L.P. | 1,706,134 | $1,860,000 | 0.18% |
| J. Goldman & Co LP | 1,045,000 | $1,139,000 | 0.06% |
| Tibra Equities Europe Ltd | 241,966 | $264,000 | 0.03% |
| IPG Investment Advisors LLC | 42,500 | $46,325,000 | 0.02% |